Exclusive Coverage of the 2017 AMERICAN COLLEGE OF RHEUMATOLOGY ANNUAL MEETING
Advertisement
Advertisement
Trending on AJMC
1
Real-World Data Show MASH Progresses Faster Than Trials Suggest
2
Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure
3
SYNC-T: Immunotherapy Platform Brings 4-Part Attack in Prostate Cancer, With More Trials Planned
4
Sarcoma's Rarity Limits Trials and Biomarker-Driven Treatment Options: Alexander Spira, MD, PhD, FACP, FASCO
5